Cheung, D. G., Buzzetti, M., Croce, C. M., & Leva, G. D. (2018). Abstract 1850: CDK inhibitor PHA-848125 preferentially inhibits proliferation of triple negative breast cancer and synergizes with cisplatin. Cancer Research, 78(13_Supplement), 1850-1850. https://doi.org/10.1158/1538-7445.am2018-1850